New Delhi, May 28 (ILNS): The Delhi High Court was today informed by the Centre that it was arranging 2.5 lakh doses of medication for Black Fungus – doses and vials of Liposomal Amphotericin B – from different countries for use on Indian patients, who have been suffering from the fungal infection post and during COVID-19.
The Bench of Justices Vipin Sanghi and Jasmeet Singh, hearing matters pertaining to issues related to the outbreak of COVID-19 in Delhi, then asked that by Monday, the Centre has to give a complete report to the court “on those 2.3 lakh vials… When are they coming, how did you get to this figure, how did you calculate it. The requirement today is much more.”
The judge was referring to Senior Advocate Rahul Mehra’s (representing the State of Delhi) comment earlier, where he had said: “10 lakh doses are required. We don’t even have 2 lakhs. We have checked globally that this disease is occurring nowhere in the world at this rate. I am not contradicting what the Centre is saying. Domestically they have done what could be done. I am talking about international aspects.”
Justice Sanghi later said: “A lot of these questions are raised and they are only arising due to lack of info, in your (the Centre’s) report.”
The Centre’s counsel, Kirtiman, said: “There are three notifications. If I am getting it for free from outside for personal use, there is no duty. The other is of one for personal use from medical facility outside. There is a charge. Third is for commercial use… there is a minimal duty.”
Justice Sanghi: “Look, this commercial use is ultimately for people.”
The court ordered: “The UOI has filed a consolidated status report which inter alia disposes the sources identified abroad by Health ministry with ministry of external affairs. The MEA has been called upon to call 2.3 lakh doses from different countries. The UOI should place before this court the detail of current status of the same to be considered on Monday, also as to how the figure of 2.3 lakh vials was arrived at and whether there is better availability of drug which could be imported.” The Bench will hear the matter again on Monday. ILNS\GM\SJ\RJ